Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy

In Italy, cervical cancer represents the fifth most prevalent cancer in women under 50 years of age and is one of the most commonly detected lesions globally. Given the developing burden of the disease and the availability of both primary and secondary prevention measures, their accurate surveillanc...

Full description

Bibliographic Details
Main Authors: Miriam Gorgone, Andrea Squeri, Sara Cuffari, Vincenza La Fauci, Ioselita Giunta, Serena Calderone, Raffaele Squeri, Cristina Genovese
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/11/1688
_version_ 1827638617617465344
author Miriam Gorgone
Andrea Squeri
Sara Cuffari
Vincenza La Fauci
Ioselita Giunta
Serena Calderone
Raffaele Squeri
Cristina Genovese
author_facet Miriam Gorgone
Andrea Squeri
Sara Cuffari
Vincenza La Fauci
Ioselita Giunta
Serena Calderone
Raffaele Squeri
Cristina Genovese
author_sort Miriam Gorgone
collection DOAJ
description In Italy, cervical cancer represents the fifth most prevalent cancer in women under 50 years of age and is one of the most commonly detected lesions globally. Given the developing burden of the disease and the availability of both primary and secondary prevention measures, their accurate surveillance is of paramount importance. The aim of this study was to evaluate the trends in cervical cancer screening adherence in the period between 2020 and 2022, as well as to evaluate positive tests, identifying the most frequently associated genotypes and the vaccination coverage. The study sample was made up of 6880 women from the health district of Messina. We highlighted that there was a high proportion of positive results in the investigated period, with a high prevalence of HSIL. Moreover, HPV vaccination coverage was clearly inadequate, as was adherence to screening, both far away from WHO goals. This finding is probably linked to inadequate communication and awareness of the issue in the population and to the lack of data relating to tests carried out privately. In accordance with existing data in the literature, the introduction of the HPV-DNA test in Sicily made it possible to identify women positive for the genotypes most frequently involved in the etiopathogenesis of neoplastic lesions (genotypes 16 and 18), as well as for those in the “others” category, which should be investigated because some of them could have an impact on carcinogenicity and, for this reason, a future vaccine including them could represent a new prevention weapon.
first_indexed 2024-03-09T16:23:36Z
format Article
id doaj.art-62c54e17442d446ca7fa53ab4e4a1da0
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T16:23:36Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-62c54e17442d446ca7fa53ab4e4a1da02023-11-24T15:10:06ZengMDPI AGVaccines2076-393X2023-11-011111168810.3390/vaccines11111688Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of ItalyMiriam Gorgone0Andrea Squeri1Sara Cuffari2Vincenza La Fauci3Ioselita Giunta4Serena Calderone5Raffaele Squeri6Cristina Genovese7Department of Biomedical and Dental Sciences and Morpho Functional Imaging, Postgraduate Medical School of Preventive Medicine and Hygiene, University of Messina, 98121 Messina, ItalyMedical Oncology Unit, Department of Human Pathology “G. Barresi”, University of Messina, 98122 Messina, ItalyLocal Health Unit of Messina, 98123 Messina, ItalyDepartment of Biomedical and Dental Sciences and Morpho Functional Imaging, University of Messina, 98124 Messina, ItalyDepartment of Biomedical and Dental Sciences and Morpho Functional Imaging, Postgraduate Medical School of Preventive Medicine and Hygiene, University of Messina, 98121 Messina, ItalyDepartment of Biomedical and Dental Sciences and Morpho Functional Imaging, Postgraduate Medical School of Preventive Medicine and Hygiene, University of Messina, 98121 Messina, ItalyDepartment of Biomedical and Dental Sciences and Morpho Functional Imaging, University of Messina, 98124 Messina, ItalyLocal Health Unit of Messina, 98123 Messina, ItalyIn Italy, cervical cancer represents the fifth most prevalent cancer in women under 50 years of age and is one of the most commonly detected lesions globally. Given the developing burden of the disease and the availability of both primary and secondary prevention measures, their accurate surveillance is of paramount importance. The aim of this study was to evaluate the trends in cervical cancer screening adherence in the period between 2020 and 2022, as well as to evaluate positive tests, identifying the most frequently associated genotypes and the vaccination coverage. The study sample was made up of 6880 women from the health district of Messina. We highlighted that there was a high proportion of positive results in the investigated period, with a high prevalence of HSIL. Moreover, HPV vaccination coverage was clearly inadequate, as was adherence to screening, both far away from WHO goals. This finding is probably linked to inadequate communication and awareness of the issue in the population and to the lack of data relating to tests carried out privately. In accordance with existing data in the literature, the introduction of the HPV-DNA test in Sicily made it possible to identify women positive for the genotypes most frequently involved in the etiopathogenesis of neoplastic lesions (genotypes 16 and 18), as well as for those in the “others” category, which should be investigated because some of them could have an impact on carcinogenicity and, for this reason, a future vaccine including them could represent a new prevention weapon.https://www.mdpi.com/2076-393X/11/11/1688cervical cancerHPVvaccinepreventionPAP testscreening
spellingShingle Miriam Gorgone
Andrea Squeri
Sara Cuffari
Vincenza La Fauci
Ioselita Giunta
Serena Calderone
Raffaele Squeri
Cristina Genovese
Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy
Vaccines
cervical cancer
HPV
vaccine
prevention
PAP test
screening
title Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy
title_full Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy
title_fullStr Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy
title_full_unstemmed Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy
title_short Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy
title_sort rates of primary and secondary prevention of cervical cancer a study in a province in the south of italy
topic cervical cancer
HPV
vaccine
prevention
PAP test
screening
url https://www.mdpi.com/2076-393X/11/11/1688
work_keys_str_mv AT miriamgorgone ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT andreasqueri ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT saracuffari ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT vincenzalafauci ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT ioselitagiunta ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT serenacalderone ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT raffaelesqueri ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly
AT cristinagenovese ratesofprimaryandsecondarypreventionofcervicalcancerastudyinaprovinceinthesouthofitaly